![]() ![]() Therefore, researchers are investigating the phases beyond COVID-19 infection and have defined it as post-acute COVID-19 syndrome, which is characterized by persistent symptoms and/or delayed or long-term complications of SARS-CoV-2 infection beyond four weeks from the onset of symptoms that affect multiple organs. The consequences after recovery from COVID-19 infection have been of special concern. Moreover, there are multiple variables that contribute to higher morbidity and mortality in COVID-19 infections such as diabetes, obesity, chronic obstructive pulmonary disease (COPD), advanced age, and male sex. According to the WHO, one out of every 20 people will require intensive care, which may involve being sedated and placed on a ventilator. ![]() Furthermore, epidemiological studies showed that the elderly population was more susceptible to developing severe diseases, while children tend to have milder symptoms. It's currently a global pandemic that's hitting almost all countries. When it comes to SARS-CoV-2 infection, it can present asymptomatically and COVID-19 presentation can range from flu-like illness up to severe complications. It is transmitted rapidly among humans by Inhalation of respiratory droplets or contact. The coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) appeared in the city of Wuhan in China, and it spread around the world. Telogen effluvium (TE) was the most prevalent type of hair loss recognized among the patients. The results suggest that hair loss is noticeably prevalent in patients following COVID-19 infection, especially in females and patients with multiple comorbidities. Our results showed that telogen effluvium (TE) was the most reported type (156, 86.7%), followed by alopecia areata (15, 8.3%) and androgenic alopecia (9, 5.0%). Our results revealed nearly half of the participants (48.5%) noticed hair loss increases by more than 120 hairs per day after COVID-19 infection, as well as half of the participants (52.6%) reported seeing hair accumulation on a pillow. ResultsĮvidence suggests that hair loss had been the most frequently reported post COVID-19 manifestation (48%). We identified 343 patients who visited the dermatology clinic for hair loss during the period 2020 to 2022. This was a record-based retrospective cross-sectional, multicenter study conducted in four centers in the Makkah region. The aim of this study is to measure the prevalence of hair loss after COVID-19 infection in Saudi Arabia, and we hope to improve the knowledge on hair loss - a cause of common dermatological consultation that frequently becomes a stressful event associated with the pandemic - among all the physicians in all the specialties. Besides that, dermatological manifestations have been reported as extra respiratory symptoms in previous studies. COVID-19, caused by SARS-CoV-2, is a worldwide pandemic with the most main symptoms seeming to be flu-like and fever.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |